Search Results
Overview
| Uniprot ID | P23497 |
|---|---|
| Protein Name | Nuclear autoantigen Sp-100 |
| Gene Name | SP100 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 300 | LVDIKKEKPFSNSKV |
| 306 | EKPFSNSKVECQAQA |
| 733 | IFAKEKGKFEDMAKA |
| 742 | EDMAKADKAHYEREM |
| 762 | PKGEKKKKFKDPNAP |
| 764 | GEKKKKFKDPNAPKR |
Function
Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to PubMed:11909962. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to PubMed:15247905. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0000781 | chromosome, telomeric region |
| Biological Process | GO:0006357 | regulation of transcription by RNA polymerase II |
| Biological Process | GO:0050792 | regulation of viral process |
| Biological Process | GO:0034097 | response to cytokine |
| Biological Process | GO:0032526 | response to retinoic acid |
| Biological Process | GO:0034340 | response to type I interferon |
| Biological Process | GO:0034341 | response to type II interferon |
| Biological Process | GO:0048384 | retinoic acid receptor signaling pathway |
| Biological Process | GO:0000723 | telomere maintenance |
| Biological Process | GO:0060337 | type I interferon-mediated signaling pathway |
| Biological Process | GO:0060333 | type II interferon-mediated signaling pathway |
| Cellular Component | GO:0005737 | cytoplasm |
| Cellular Component | GO:0016604 | nuclear body |
| Cellular Component | GO:0034399 | nuclear periphery |
| Cellular Component | GO:0005730 | nucleolus |
| Cellular Component | GO:0005654 | nucleoplasm |
| Cellular Component | GO:0005634 | nucleus |
| Cellular Component | GO:0016605 | PML body |
| Molecular Function | GO:0070087 | chromo shadow domain binding |
| Molecular Function | GO:0003677 | DNA binding |
| Molecular Function | GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific |
| Molecular Function | GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Molecular Function | GO:0042802 | identical protein binding |
| Molecular Function | GO:0019900 | kinase binding |
| Molecular Function | GO:0046983 | protein dimerization activity |
| Molecular Function | GO:0019904 | protein domain specific binding |
| Molecular Function | GO:0042803 | protein homodimerization activity |
| Molecular Function | GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding |
| Molecular Function | GO:0003714 | transcription corepressor activity |
| Biological Process | GO:0030330 | DNA damage response, signal transduction by p53 class mediator |
| Biological Process | GO:0006351 | DNA-templated transcription |
| Biological Process | GO:0045185 | maintenance of protein location |
| Biological Process | GO:0045892 | negative regulation of DNA-templated transcription |
| Biological Process | GO:0010596 | negative regulation of endothelial cell migration |
| Biological Process | GO:0046826 | negative regulation of protein export from nucleus |
| Biological Process | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| Biological Process | GO:0032897 | negative regulation of viral transcription |
| Biological Process | GO:0045944 | positive regulation of transcription by RNA polymerase II |
| Biological Process | GO:0045765 | regulation of angiogenesis |
| Biological Process | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| Biological Process | GO:1902044 | regulation of Fas signaling pathway |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[2] He C, Zhang J, Bai X, Lu C, Zhang K. Lysine lactylation-based insight to understanding the characterization of cervical cancer.. Biochim Biophys Acta Mol Basis Dis 1870(7):167356. 2024 Oct. PMID: 39025375.